Law FirmOpposition Filing Analysis

The comprehensive analysis of Hamm & Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hamm & Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025BETAPHARM ARZNEIMITTEL
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025SYNTHON
Anticancer CompositionsARAGON PHARMACEUTICALSJul 7, 2025HAMM & WITTKOPP
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025STADA ARZNEIMITTEL
Solid State Forms Of Mavacamten And Process For Preparation ThereofASSIA CHEMICAL INDUSTRIESJun 18, 2025HAMM & WITTKOPP
Compositions Of 1-(4-Bromo-5-(1-Ethyl-7-(Methylamino)-2-Oxo-1,2-Dihydro-1,6-Naphthyridin-3-Yl)-2-Fluorophenyl)-3-PhenylureaDECIPHERA PHARMACEUTICALSMay 28, 2025ALFRED E TIEFENBACHER
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025SYNTHON
Liquid Formulations Of (S)-N-(5-((R)-2-(2,5-Difluorophenyl)-Pyrrolidin-1-Yl)-Pyrazolo[1,5-A]Pyrimidin-3-Yl)-3-Hydroxypyrrolidine-1-CarboxamideLOXO ONCOLOGYApr 11, 2025SYNTHON
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTMar 20, 2025HAMM & WITTKOPP
Methods For Ensuring Resuspension Of Paliperidone Palmitate FormulationsJANSSEN PHARMACEUTICAFeb 17, 2025HAMM & WITTKOPP